5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 6.68▼ | 6.70▼ | 6.71▼ | 6.84▼ | 6.48▲ |
MA10 | 6.69▼ | 6.72▼ | 6.74▼ | 6.53▲ | 6.24▲ |
MA20 | 6.70▼ | 6.76▼ | 6.82▼ | 6.38▲ | 6.25▲ |
MA50 | 6.73▼ | 6.85▼ | 6.82▼ | 6.05▲ | 7.21▼ |
MA100 | 6.77▼ | 6.75▼ | 6.36▲ | 6.32▲ | 10.65▼ |
MA200 | 6.84▼ | 6.33▲ | 6.41▲ | 7.03▼ | 22.64▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.002▼ | -0.007▼ | -0.027▼ | 0.059▲ | 0.188▲ |
RSI | 43.256▼ | 43.458▼ | 45.021▼ | 54.765▲ | 49.400▼ |
STOCH | 23.958 | 33.005 | 23.459 | 83.600▲ | 67.755 |
WILL %R | -81.250▼ | -82.143▼ | -88.235▼ | -27.660 | -29.412 |
CCI | -77.333 | -103.187▼ | -108.546▼ | 49.803 | 123.087▲ |
Friday, June 13, 2025 04:15 PM
Ramkumar Mandalam, a director at $CYRX, sold 624 shares of the company on 06-13-2025 for an estimated $4,246. We received data on the trade from a recent SEC filing ...
|
Thursday, June 12, 2025 05:00 AM
Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a leader in temperature-controlled supply chain solutions for the Life Sciences, with a focus on regenerative medicine, today announced the ...
|
Monday, June 09, 2025 12:59 PM
The average of price targets set by Wall Street analysts indicates a potential upside of 81.4% in CryoPort (CYRX). While the effectiveness of this highly sought-after metric is questionable ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 6.61 | 6.8734 | 6.55 | 6.67 | 589,576 |
12/06/25 | 6.98 | 7.09 | 6.66 | 6.90 | 424,907 |
11/06/25 | 6.79 | 7.05 | 6.79 | 6.91 | 433,503 |
10/06/25 | 6.955 | 6.975 | 6.74 | 6.77 | 412,467 |
09/06/25 | 7.02 | 7.19 | 6.715 | 6.96 | 489,470 |
06/06/25 | 6.81 | 7.105 | 6.73 | 7.00 | 622,086 |
05/06/25 | 6.14 | 6.71 | 6.05 | 6.66 | 532,878 |
04/06/25 | 5.86 | 6.255 | 5.65 | 6.18 | 387,235 |
03/06/25 | 5.40 | 5.87 | 5.31 | 5.84 | 415,461 |
02/06/25 | 5.99 | 6.08 | 5.39 | 5.40 | 700,491 |
|
|
||||
|
|
||||
|
|